AU2001279630A1 - Tumor activated prodrug compounds - Google Patents
Tumor activated prodrug compoundsInfo
- Publication number
- AU2001279630A1 AU2001279630A1 AU2001279630A AU7963001A AU2001279630A1 AU 2001279630 A1 AU2001279630 A1 AU 2001279630A1 AU 2001279630 A AU2001279630 A AU 2001279630A AU 7963001 A AU7963001 A AU 7963001A AU 2001279630 A1 AU2001279630 A1 AU 2001279630A1
- Authority
- AU
- Australia
- Prior art keywords
- prodrug compounds
- activated prodrug
- tumor activated
- tumor
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 229940002612 prodrug Drugs 0.000 title 1
- 239000000651 prodrug Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US20899600P | 2000-06-01 | 2000-06-01 | |
| US60/208,996 | 2000-06-01 | ||
| EP00870130 | 2000-06-15 | ||
| EP00870130.2 | 2000-06-15 | ||
| EP00870306 | 2000-12-18 | ||
| EP00870306.8 | 2000-12-18 | ||
| PCT/EP2001/006106 WO2001091798A2 (en) | 2000-06-01 | 2001-05-29 | Tumor activated prodrug compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001279630A1 true AU2001279630A1 (en) | 2001-12-11 |
Family
ID=27223761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001279630A Abandoned AU2001279630A1 (en) | 2000-06-01 | 2001-05-29 | Tumor activated prodrug compounds |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JP2003534387A (en) |
| AU (1) | AU2001279630A1 (en) |
| CA (1) | CA2408103A1 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU9399501A (en) | 2000-10-09 | 2002-04-22 | Isis Innovation | Therapeutic antibodies |
| CA3128656A1 (en) * | 2007-08-22 | 2009-02-26 | The Regents Of The University Of California | Activatable binding polypeptides and methods of identification and use thereof |
| JP5851842B2 (en) | 2009-01-12 | 2016-02-03 | サイトムエックス セラピューティクス, インク.CytomX Therapeutics, Inc. | Modified antibody composition and methods of making and using the same |
| KR101619816B1 (en) | 2009-01-19 | 2016-05-13 | 한미사이언스 주식회사 | Oligonucleotide complex comprising an immunoglobulin Fc fragment |
| AU2010215761B2 (en) * | 2009-02-23 | 2017-04-06 | Cytomx Therapeutics, Inc | Proproteins and methods of use thereof |
| KR20200086312A (en) * | 2017-11-08 | 2020-07-16 | 야페이 상하이 바이오로그 메디신 사이언스 앤드 테크놀로지 컴퍼니 리미티드 | Biomolecule conjugates and uses thereof |
-
2001
- 2001-05-29 CA CA002408103A patent/CA2408103A1/en not_active Abandoned
- 2001-05-29 AU AU2001279630A patent/AU2001279630A1/en not_active Abandoned
- 2001-05-29 JP JP2001587810A patent/JP2003534387A/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| CA2408103A1 (en) | 2001-12-06 |
| JP2003534387A (en) | 2003-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002222853A1 (en) | Therapeutic compounds | |
| AU2002225730A1 (en) | Compounds | |
| AU2002218266A1 (en) | Novel indanylidene compounds | |
| AU2001292518A1 (en) | Novel compounds | |
| AU2001266345A1 (en) | Five-membered-ring compound | |
| AU2001252599A1 (en) | Remedies for cancer | |
| AU4430701A (en) | Compounds for targeting | |
| AU2001248748A1 (en) | Substituted piperazine compounds | |
| AUPQ661800A0 (en) | Insulin-potentiating compounds | |
| AU2001239765A1 (en) | Novel compounds | |
| AU2001277711A1 (en) | Remedies for cisplatin-tolerant cancer | |
| AU2001246998A1 (en) | Novel compounds | |
| AU2001253362A1 (en) | Novel compounds | |
| AU2000263864A1 (en) | Tissue specific prodrug | |
| AU2002231077A1 (en) | Novel compounds | |
| AU2001238590A1 (en) | Substituted piperazine compounds | |
| AU2001256964A1 (en) | Novel compounds | |
| AU7130101A (en) | Enzyme-cleavable prodrug compounds | |
| AU2002225724A1 (en) | Motilide compounds | |
| AU2002220684A1 (en) | Fap-alpha-activated anti-tumor compounds | |
| AU2001279630A1 (en) | Tumor activated prodrug compounds | |
| AU2002217285A1 (en) | Compounds | |
| AU2001230689A1 (en) | Novel compounds | |
| AU2001277857A1 (en) | Tumor necrosis factor-gamma | |
| AU2002216060A1 (en) | Novel compounds |